Interestingly, fluvoxamine, a commonly used medication for treating anxiety and depression, exhibits anti-fibrotic effects by inhibiting the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway and related signaling pathways (13), making it a potential effective treatment for IPF. The gene discussed is CGAS; the disease is depressive disorder.